Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Supportive Care in Cancer
Published in: Supportive Care in Cancer 4/2016

01-04-2016 | Letter to the editor

Integrative medicine, quality of life and gynecological cancer

Comments on the article titled “Quality-of-life outcomes in patients with gynecologic cancer referred to integrative oncology treatment during chemotherapy”

Authors: Cristiana Alves Cesar-Netto, Ana Elisa Colombo, Cristina Frange, Monica Levy Andersen, Sergio Tufik, Helena Hachul

Published in: Supportive Care in Cancer | Issue 4/2016

Login to get access

Excerpt

We congratulate Ben-Arye et al. [1] for their recent study titled “Quality-of-life outcomes in patients with gynecologic cancer referred to integrative oncology treatment during chemotherapy” published in Supportive Care in Cancer. Their great initiative elucidates an improvement in patient quality of life due to the use of complementary and integrative medicine. The authors investigated the most common concerns expressed by gynecologic cancer patients during chemotherapy and the influence of complementary medicine on these symptoms, observing a reduction therein. …
Literature
1.
Ben-Arye E, Samuels N, Schiff E, Raz OG, Sharabi IS, Lavie O (2015) Quality-of-life outcomes in patients with gynecologic cancer referred to integrative oncology treatment during chemotherapy. Support Care Cancer [Epub ahead of print]. doi:10.​1007/​s00520-015-2690-0
2.
3.
Holmberg C, Brinkhaus B, Witt C (2012) Experts’ opinions on terminology for complementary and integrative medicine—a qualitative study with leading experts. BMC Complement Altern Med 14:218. doi:10.​1186/​1472-6882-12-218 CrossRef
4.
The WHOQOL Group (1995) The World Health Organization quality of life assessment (WHOQOL): position paper from the World Health Organization. Soc Sci Med 10:1403–1409. doi:10.​1016/​0277-9536(95)00112-K
5.
Croom AR, Hamann HA, Kehoe SM, Paulk E, Wiebe DJ (2013) Illness perceptions matter: understanding quality of life and advanced illness behaviors in female patients with late-stage cancer. J Support Oncol 11:165–173. doi:10.​1080/​15524256.​2014.​906372 PubMed
6.
Kleitman N (1963) Sleep and wakefulness. University of Chicago Press, Chicago
7.
8.
Webster K, Cella D, Yost K (2003) The Functional Assessment of Chronic Illness Therapy (FACIT) Measurement System: properties, applications, and interpretation. Health and Quality of Life Outcomes
Metadata
Title
Integrative medicine, quality of life and gynecological cancer
Comments on the article titled “Quality-of-life outcomes in patients with gynecologic cancer referred to integrative oncology treatment during chemotherapy”
Authors
Cristiana Alves Cesar-Netto
Ana Elisa Colombo
Cristina Frange
Monica Levy Andersen
Sergio Tufik
Helena Hachul
Publication date
01-04-2016
Publisher
Springer Berlin Heidelberg
Published in
Supportive Care in Cancer / Issue 4/2016
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-015-3022-0

Other articles of this Issue 4/2016

Supportive Care in Cancer 4/2016 Go to the issue

Original Article

Effects of adjuvant chemotherapy on recurrence, survival, and quality of life in stage II colon cancer patients: a 24-month follow-up

Letter to the editor

Designing an integrative gynecologic oncology model of supportive care: call for a cross-cultural international collaboration

Original Article

A randomised controlled trial comparing the effects of a 12-week supervised exercise versus usual care on outcomes in haematological cancer patients

Original Article

Sotatercept (ACE-011) for the treatment of chemotherapy-induced anemia in patients with metastatic breast cancer or advanced or metastatic solid tumors treated with platinum-based chemotherapeutic regimens: results from two phase 2 studies

Original Article

Cancer patients’ respect experiences in relation to perceived communication behaviours from hospital staff: analysis of the 2012–2013 National Cancer Patient Experience Survey

Original Article

Patient-centered outcome evaluation of the Rural Breast Cancer Survivors Intervention
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits